Target Price | €47.23 |
Price | €41.19 |
Potential | 14.67% |
Number of Estimates | 17 |
17 Analysts have issued a price target Qiagen 2025 . The average Qiagen target price is €47.23. This is 14.67% higher than the current stock price. The highest price target is €55.27 34.18% , the lowest is €39.38 4.40% . | |
A rating was issued by 20 analysts: 12 Analysts recommend Qiagen to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Qiagen stock has an average upside potential 2025 of 14.67% . Most analysts recommend the Qiagen stock at Purchase. |
16 Analysts have issued a sales forecast Qiagen 2024 . The average Qiagen sales estimate is €1.8b . This is 1.14% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €1.8b 2.69% , the lowest is €1.8b 0.96% .
This results in the following potential growth metrics:
2023 | €1.8b | 10.79% |
---|---|---|
2024 | €1.8b | 0.15% |
2025 | €1.9b | 5.88% |
2026 | €2.1b | 6.90% |
2027 | €2.2b | 7.05% |
2028 | €2.4b | 7.88% |
12 Analysts have issued an Qiagen EBITDA forecast 2024. The average Qiagen EBITDA estimate is €666m . This is 9.19% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €727m 19.17% , the lowest is €626m 2.56% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €602m | 19.40% |
---|---|---|
2024 | €666m | 10.73% |
2025 | €712m | 6.93% |
2026 | €770m | 8.10% |
2027 | €804m | 4.41% |
2028 | €866m | 7.72% |
2023 | 33.10% | 9.65% |
---|---|---|
2024 | 36.71% | 10.89% |
2025 | 37.07% | 0.98% |
2026 | 37.49% | 1.13% |
2027 | 36.57% | 2.45% |
2028 | 36.51% | 0.16% |
5 Qiagen Analysts have issued a net profit forecast 2024. The average Qiagen net profit estimate is €100.0m . This is 55.11% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €111m 72.54% , the lowest is €94.6m 46.77% .
This results in the following potential growth metrics and future Net Margins:
2023 | €313m | 21.67% |
---|---|---|
2024 | €100.0m | 68.10% |
2025 | €413m | 312.91% |
2026 | €460m | 11.40% |
2027 | €514m | 11.79% |
2028 | €567m | 10.34% |
2023 | 17.24% | 12.20% |
---|---|---|
2024 | 5.51% | 68.04% |
2025 | 21.48% | 289.84% |
2026 | 22.38% | 4.19% |
2027 | 23.38% | 4.47% |
2028 | 23.91% | 2.27% |
5 Analysts have issued a Qiagen forecast for earnings per share. The average Qiagen <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €0.45 . This is 55.17% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €0.50 72.41% , the lowest is €0.43 48.28% .
This results in the following potential growth metrics and future valuations:
2023 | €1.41 | 21.67% |
---|---|---|
2024 | €0.45 | 68.09% |
2025 | €1.86 | 313.33% |
2026 | €2.07 | 11.29% |
2027 | €2.31 | 11.59% |
2028 | €2.55 | 10.39% |
Current | 144.07 | 476.97% |
---|---|---|
2024 | 92.45 | 36.44% |
2025 | 22.39 | 75.78% |
2026 | 20.10 | 10.23% |
2027 | 17.98 | 10.55% |
2028 | 16.29 | 9.40% |
Based on analysts' sales estimates for 2024, the Qiagen stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.35 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 5.08 .
This results in the following potential growth metrics and future valuations:
Current | 5.36 | 8.28% |
---|---|---|
2024 | 5.35 | 1.19% |
2025 | 5.05 | 5.55% |
2026 | 4.72 | 6.45% |
2027 | 4.41 | 6.58% |
2028 | 4.09 | 7.31% |
Current | 5.09 | 8.74% |
---|---|---|
2024 | 5.08 | 1.12% |
2025 | 4.80 | 5.55% |
2026 | 4.49 | 6.45% |
2027 | 4.20 | 6.58% |
2028 | 3.89 | 7.31% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.